Aspiriant LLC Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Dow Jones International Real Estate ETF
RWX
|
+$70.7M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$52.3M |
| 3 |
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
|
+$51.6M |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$28.9M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$16.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$10.2M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$4.27M |
| 3 |
GSP
Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index
GSP
|
+$1.57M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$902K |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$858K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 3.6% |
| 2 | Industrials | 0.69% |
| 3 | Consumer Staples | 0.51% |
| 4 | Communication Services | 0.31% |
| 5 | Healthcare | 0.31% |
Similar funds
Aspiriant LLC's Q2 2015 Portfolio in Review
As of Q2 2015, Aspiriant LLC held 118 positions worth $1.02B, up 33% from $771M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Aspiriant LLC deployed $270M of net new capital in Q2 2015, opening 28 new positions and adding to 56 existing holdings. Its largest new stake was iShares MSCI Emerging Markets Min Vol Factor ETF: 849,692 shares worth $49M.
By sector, the portfolio is most concentrated in Financials at 3.6% of assets, down from 5.5% a quarter earlier, followed by Industrials and Consumer Staples.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $10.2M trimmed.
- Aspiriant LLC's largest Q2 2015 buy was iShares MSCI Emerging Markets Min Vol Factor ETF: 849,692 shares worth $49M.
- Aspiriant LLC added most to State Street SPDR Dow Jones International Real Estate ETF in Q2 2015, an estimated $70.7M increase.
- Aspiriant LLC's biggest Q2 2015 reduction was iShares Core S&P 500 ETF, cutting an estimated $10.2M.
- Aspiriant LLC fully exited Cimpress in Q2 2015, selling an estimated $641K.
- Aspiriant LLC's ten largest holdings make up 80% of its $1.02B portfolio in Q2 2015.
- Aspiriant LLC opened 28 new positions and closed 4 in Q2 2015.
- Aspiriant LLC's portfolio value rose 33% quarter-over-quarter to $1.02B.
Based on Aspiriant LLC's 13F filing for Q2 2015, filed 6 Aug 2015.